Statewide
Utah Department of Public Safety, Bureau of Emergency Medical Services
Utah Department of Public Safety, Bureau of Emergency Medical Services (UT) carries 35 drugs across 144 dose entries in its current published protocol, effective 2025-09-01.
Drugs and doses35
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 500–1000 mg | PO | not captured | standing | page 55 |
| Other | adult | 500–1000 mg | IV | not captured | standing | page 55 |
| Other | peds | 15 mg/kg | PO | not captured | standing | page 55 |
| Other | peds | 15 mg/kg | IV | not captured | standing | page 55 |
| Mild to moderate pain | adult | 500–1000 mg | PO | not captured | standing | page 20 |
| Mild to moderate pain | adult | 500–1000 mg | IV | not captured | standing | page 21 |
| Mild to moderate pain | peds | 15 mg/kg | PO | not captured | standing | page 20 |
| Mild to moderate pain | peds | 15 mg/kg | IV | not captured | standing | page 21 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 6 mg | IV | not captured | standing | page 44 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg | IV | not captured | standing | page 44 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | page 49 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | page 49 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 300 mg | IV/IO | not captured | standing | page 35 |
| Cardiac arrest | peds | 5 mg/kg | IV/IO | not captured | standing | page 35 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 325 mg | PO | not captured | standing | page 37 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | page 32 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 32 |
| Nerve agent exposure | adult | 2 mg | IV/IM | not captured | standing | page 76 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | page 36 |
| Hyperkalemia | peds | 20 mg/kg | IV/IO | not captured | standing | page 36 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 3 g | IV/IO | not captured | standing | page 36 |
| Hyperkalemia | peds | 100 mg/kg | IV/IO | not captured | standing | page 36 |
| Other | adult | 1 g | PO | not captured | standing | page 74 |
| Other | adult | 1000 mg | IV | not captured | standing | page 75 |
| Other | peds | 1 g | PO | not captured | standing | page 74 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 12.5 g | IV/IO | not captured | standing | page 57 |
| Hypoglycemia | peds | 5 mL/kg | IV/IO | not captured | standing | page 57 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 5 mg | IV/IO | not captured | standing | page 52 |
| Agitation | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 52 |
| Agitation | peds | 0.2 mg/kg | IM | not captured | standing | page 52 |
| Other | adult | 10 mg | IM | not captured | standing | page 70 |
| Other | adult | 5 mg | IV/IO | not captured | standing | page 70 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 70 |
| Other | peds | 0.2 mg/kg | IM | not captured | standing | page 70 |
| Seizure | adult | 10 mg | IM | not captured | standing | page 66 |
| Seizure | adult | 5 mg | IV/IO | not captured | standing | page 66 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 66 |
| Seizure | peds | 0.2 mg/kg | IM | not captured | standing | page 66 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 1 mg/kg | IV/IO/IM | not captured | standing | page 50 |
| Anaphylaxis | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 50 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.5 mg | IM | not captured | standing | page 49 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | page 49 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 34 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 34 |
| Head injury / TBI | adult | 0.05–1 mcg/kg | IV/IO | not captured | standing | page 97 |
| Head injury / TBI | peds | 0.05–1 mcg/kg | IV/IO | not captured | standing | page 97 |
| Hypotension / shock | adult | 10–20 mcg | IV/IO | not captured | standing | page 26 |
| Hypotension / shock | peds | 1 mcg/kg | IV/IO | not captured | standing | page 26 |
| Opioid overdose | adult | 0.05–1 mcg/kg | IV/IO | not captured | standing | page 62 |
| Opioid overdose | peds | 0.05–1 mcg/kg | IV/IO | not captured | standing | page 62 |
| Other | adult | 0.05–1 mcg/kg | IV/IO | not captured | standing | page 54 |
| Other | adult | 0.05–1 mcg/kg | IV/IO | not captured | standing | page 95 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 25–100 mcg | IV/IO/IM/IN | not captured | standing | page 21 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 21 |
| Post-ROSC care | adult | 50–100 mcg | IV | not captured | standing | page 24 |
| Post-ROSC care | peds | 0.5 mcg/kg | IV | not captured | standing | page 24 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | page 57 |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2–5 mg | IV/IO | not captured | standing | page 52 |
| Agitation | adult | 5–10 mg | IM | not captured | standing | page 52 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Carbon monoxide poisoning | adult | 5 g | IV/IO | not captured | standing | page 71 |
| Carbon monoxide poisoning | peds | 70 mg/kg | IV/IO | not captured | standing | page 71 |
| Cyanide poisoning | adult | 5 g | IV/IO | not captured | standing | page 72 |
| Cyanide poisoning | peds | 70 mg/kg | IV/IO | not captured | standing | page 72 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 600 mg | PO | not captured | standing | page 55 |
| Other | peds | 10 mg/kg | PO | not captured | standing | page 55 |
| Mild to moderate pain | adult | 600 mg | PO | not captured | standing | page 20 |
| Mild to moderate pain | peds | 10 mg/kg | PO | not captured | standing | page 20 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | page 64 |
| Asthma / bronchospasm | peds | 0.5 mg | NEB | not captured | standing | page 64 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 1 mg/kg | IV/IO | not captured | standing | page 52 |
| Agitation | adult | 4 mg/kg | IM | not captured | standing | page 52 |
| Mild to moderate pain | adult | 10–20 mg | IV/IO | not captured | standing | page 21 |
| Mild to moderate pain | peds | 0.15–0.3 mg/kg | IV/IO | not captured | standing | page 21 |
| Post-ROSC care | adult | 100 mg | IV | not captured | standing | page 24 |
| Post-ROSC care | peds | 1 mg/kg | IV | not captured | standing | page 24 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 15 mg | IV | not captured | standing | page 21 |
| Mild to moderate pain | adult | 30 mg | IM | not captured | standing | page 21 |
| Mild to moderate pain | peds | 0.5 mg/kg | IV | not captured | standing | page 21 |
| Mild to moderate pain | peds | 0.5 mg/kg | IM | not captured | standing | page 21 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg/kg | IV/IO | not captured | standing | page 36 |
| Other | peds | 1 mg/kg | IV/IO | not captured | standing | page 36 |
| VF / pulseless VT | adult | 1 mg/kg | IV/IO | not captured | standing | page 35 |
| VF / pulseless VT | peds | 1 mg/kg | IV/IO | not captured | standing | page 35 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2 mg | IV/IO | not captured | standing | page 52 |
| Agitation | peds | 0.05 mg/kg | IV/IO | not captured | standing | page 52 |
| Agitation | peds | 0.05 mg/kg | IM | not captured | standing | page 52 |
| Other | adult | 1–2 mg | IV/IO/IM | not captured | standing | page 70 |
| Other | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 70 |
| Seizure | adult | 4 mg | IV/IO/IM | not captured | standing | page 66 |
| Seizure | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 66 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV | not captured | standing | page 64 |
| Asthma / bronchospasm | peds | 50 mg/kg | IV | not captured | standing | page 64 |
| Eclampsia / pre-eclampsia | adult | 5 g | IV/IO/IM | not captured | standing | page 60 |
| Eclampsia / pre-eclampsia | peds | 5 g | IV/IO/IM | not captured | standing | page 60 |
| Other | adult | 2 g | IV/IO | not captured | standing | page 36 |
| Other | peds | 50 mg/kg | IV/IO | not captured | standing | page 36 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5–5 mg | IV/IO | not captured | standing | page 52 |
| Agitation | adult | 5 mg | IM/IN | not captured | standing | page 52 |
| Agitation | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 52 |
| Agitation | peds | 0.2 mg/kg | IM/IN | not captured | standing | page 52 |
| Post-ROSC care | adult | 2.5 mg | IV | not captured | standing | page 24 |
| Post-ROSC care | peds | 0.05 mg/kg | IV | not captured | standing | page 24 |
| Seizure | adult | 10 mg | IM | not captured | standing | page 66 |
| Seizure | adult | 5 mg | IV/IO/IN | not captured | standing | page 66 |
| Seizure | peds | 0.1 mg/kg | IV/IO/IN | not captured | standing | page 66 |
| Seizure | peds | 0.2 mg/kg | IM | not captured | standing | page 66 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 2–10 mg | IV/IO/IM | not captured | standing | page 21 |
| Mild to moderate pain | peds | 0.05–0.1 mg/kg | IV/IO/IM | not captured | standing | page 21 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4–2 mg | IV/IO/IM/IN | not captured | standing | page 11 |
| Opioid overdose | adult | 3–8 mg | IN | not captured | standing | page 61 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 11 |
Nerve Agent Antidote Kit
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 1-3 Kits | IM | not captured | standing | page 76 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 37 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 39 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.05–1 mcg/kg | IV/IO | not captured | standing | page 50 |
| Anaphylaxis | peds | 0.05–1 mcg/kg | IV/IO | not captured | standing | page 50 |
| Cardiac arrest | adult | 0.05–1 mcg/kg | IV/IO | not captured | standing | page 43 |
| Cardiac arrest | peds | 0.05–1 mcg/kg | IV/IO | not captured | standing | page 43 |
| CHF / pulmonary edema | adult | 0.05–1 mcg/kg | IV/IO | not captured | standing | page 40 |
| CHF / pulmonary edema | peds | 0.05–1 mcg/kg | IV/IO | not captured | standing | page 40 |
| Head injury / TBI | adult | 0.05–1 mcg/kg | IV/IO | not captured | standing | page 97 |
| Head injury / TBI | peds | 0.05–1 mcg/kg | IV/IO | not captured | standing | page 97 |
| Hypotension / shock | adult | 0.05–1 mcg/kg | IV/IO | not captured | standing | page 27 |
| Hypotension / shock | peds | 0.05–1 mcg/kg | IV/IO | not captured | standing | page 27 |
| Opioid overdose | adult | 0.05–1 mcg/kg | IV/IO | not captured | standing | page 62 |
| Opioid overdose | peds | 0.05–1 mcg/kg | IV/IO | not captured | standing | page 62 |
| Other | adult | 0.05–1 mcg/kg | IV/IO | not captured | standing | page 54 |
| Other | peds | 0.05–1 mcg/kg | IV/IO | not captured | standing | page 54 |
| Post-ROSC care | adult | 0.05–1 mcg/kg | IV/IO | not captured | standing | page 43 |
| Post-ROSC care | peds | 0.05–1 mcg/kg | IV/IO | not captured | standing | page 43 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | ODT | not captured | standing | page 18 |
| Nausea / vomiting | adult | 4–8 mg | IV/IM/PO | not captured | standing | page 18 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IM/PO | not captured | standing | page 18 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15 g | PO | not captured | standing | page 56 |
| Hypoglycemia | peds | 7.5 g | PO | not captured | standing | page 56 |
Oxytocin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 10 unit | IM | not captured | standing | page 58 |
| Obstetric hemorrhage | adult | 10 unit | IV/IO | not captured | standing | page 60 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 12.5–25 mg | IV | not captured | standing | page 18 |
| Nausea / vomiting | adult | 25 mg | IM | not captured | standing | page 18 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 1 mEq/kg | IV/IO | not captured | standing | page 36 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | page 36 |
| Tricyclic overdose | adult | 1 mEq/kg | IV/IO | not captured | standing | page 62 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 1 g | IV | not captured | standing | page 60 |
| Obstetric hemorrhage | peds | 15 mg/kg | IV | not captured | standing | page 60 |